JACK E STOVER
CIK 1203603 · President and CEO · last filed 2026-07-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.94M
Companies
8
Total Filings
44
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAW | Director | 6,165 | $0.51 | $3.2K | $0 | 5 | 2026-07-14 |
| PFSA | Director | 295 | $1.04 | $307 | $0 | 3 | 2026-05-06 |
| ONTX | Director | — | $13.05 | — | $0 | 4 | 2023-08-14 |
| INTERPACE BIOSCIENCES, INC. (IDXG) Delisted | President and CEO | 30,271 | $1.67 | $50.6K | $0 | 5 | 2020-12-02 |
| Traws Pharma, Inc. (ONTXW) Delisted | Director | 47,110 | $0.07 | $3.2K | $0 | 5 | 2020-07-10 |
| LINC | President and CEO | 427,300 | $42.06 | $17.97M | $0 | 7 | 2019-03-15 |
| INTERPACE BIOSCIENCES, INC. (PDII) Delisted | Director | 97,378 | — | — | $0 | 8 | 2015-06-04 |
| AIS | President and CEO | 276,666 | $61.33 | $16.97M | $0 | 4 | 2008-05-16 |
Recent Filings · Page 2 of 5
44 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-30 | ONTX | Grant (A) | — | $0 | EDGAR |
| 2020-12-02 | INTERPACE BIOSCIENCES, INC. (IDXG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-10 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-06 | INTERPACE BIOSCIENCES, INC. (IDXG) Delisted | Grant (A) | +7,188 | $0 | EDGAR |
| 2020-02-10 | INTERPACE BIOSCIENCES, INC. (IDXG) Delisted | — | — | $0 | EDGAR |
| 2020-01-24 | INTERPACE BIOSCIENCES, INC. (IDXG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-29 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-15 | LINC | Grant (A) | +86,922 | $0 | EDGAR |
| 2019-03-08 | LINC | Grant (A) | +87,000 | $0 | EDGAR |
| 2018-12-06 | LINC | Grant (A) | +60,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.